Lundbeck acquires North-American rights for nalmefene from Somaxon
Related to this, Biotie-Lundbeck licensing agreement terms have been amended. Under the terms of the amended agreement, Biotie is now eligible for up to E84 million in upfront
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced plans to launch a new AI sandbox to expedite the development of medicines and improve safety.
In the BST-CarGel study, VirtualScopics is providing blinded data analysis of quantitative magnetic resonance imaging which will allow BioSyntech to demonstrate BST-CarGel’s potential for affecting the quantity and